Member Info for Mkx007

This is going to rise comfortably but it's not going to be a short term recovery like most are hoping for. Once it gets back up to £20. We will all be laughing.

As far as I'm reading into these results everything is positive. Obviously the Advair announcement earlier is weighing over them but it looks like the outlook is positive in terms of discussion with the FDA. What do others think?

Had a similar experience but my entries were a bit lower down. First at 1800 then 1600 then 1400. Didn't go in again as it didn't seem worth. Any positive product news and this will turn the corner but the asthma treatment falling through didn't help.

It's probably not worth the risk. But it will return to the heights of 1600-1800 at some point this year. Might be good to jump back in at another level.

Yeah exactly. I've been watching this for a while and not seen it this low without bouncing back strongly. It must be somewhere near the bottom. Freefalling this far must have caught the attention of the big guns.

Yeah seems the drop must be the start of the end. It's significantly slowed. Down. This might be my long haul for the year. A good 600, 700 per 100 of my shares of potential value. Should have decent profit margins this year. The delays didn't help but it's a pharma company they have money all over and have benefited from Trumps plans over Clinton plans. Hold out for 1800 on the bounce. Stop loss it and let it rise.

Not quite the same level as you but I thought what you thought at 1600. Tempted to add another 100 to the pile. Will see what the outlook is from here but it's definitely due a rise. Any key dates coming up?

Thought exactly the same, not seen it this low for a while. Can't see any reason apart from the threat from the health Bill but that looked priced in. Ready for it to bounce back to 1800